Moses 2.0 vs Magneto for HoLEP - a Randomized Controlled Trial
Northwestern University · with Cook Group Incorporated · NCT07632742
Opens the official ClinicalTrials.gov record, with the study team’s contacts. Bored Studies doesn’t enroll anyone.
Key facts
- Compensation
- Not posted. Ask the study team before screening.
- Who can join
- Ages 18–100 · Men only
- Healthy volunteers
- Accepted
- Study type
- Interventional · Not applicable
- Target enrollment
- 180
- US sites recruiting
- 1
- Study start
- May 29, 2026
- Record last updated
- October 15, 2026
Status re-checked against ClinicalTrials.gov within the last 12 hours.
What the study is about
The objective of this study is to compare the Magneto 150 holmium laser to the current MOSES 2.0 technology to see if there is a benefit in decreased hemostasis time intraoperatively.
Being studied: Magneto 150 holmium laser; Moses 2.0 holmium laser
Conditions: Enlarged Prostate (BPH); Benign Prostatic Hyperplasia
Eligibility criteria
Copied from the official record. The study team makes the final decision at screening.
Show full criteria
Inclusion Criteria
- Undergoing HoLEP for the treatment of bothersome lower urinary tract symptoms
- Internet access and a device to complete postoperative questionnaires (smartphone, tablet, laptop or desktop computer)
Exclusion Criteria
- Patients who lack decisional capacity
- Patients unable to read/speak English
- Patients who are on a blood thinner (anticoagulation medication)
- Patients who do not have internet access to complete postoperative surveys
Recruiting US locations
Northwestern University
Chicago, IL 60611
Site contact: Alyssa McDonald, MPH · 312-695-8146 · alyssa.mcdonald@northwestern.edu
Study contacts (from the official record)
- Alyssa McDonald, MPH · 312-695-8146 · alyssa.mcdonald@northwestern.edu
Similar studies in Illinois
All healthy volunteers studies in Illinois →- RecruitingHealthy volunteers
J-RISE: Relevant Implementation Strategies to Eliminate the Social and Structural Barriers to HIV Services Among Justice-involved Black Men Who Have Sex With Men and Other Key Populations
University of Chicago
- Location
- Chicago, IL
- Eligibility basics
- Ages 18+
- RecruitingHealthy volunteersPhase 1/Phase 2
Phase 1/2 Study of Respiratory Syncytial Virus and Human Metapneumovirus (RSV+HMPV) Vaccine Candidate in Adults 60 Years of Age and Older
Sanofi
- Location
- Melrose Park, IL + 49 other US sites
- Eligibility basics
- Ages 60+
- RecruitingHealthy volunteersPhase 1
A Study to Assess Safety, Tolerability, and How Single and Multiple Injections or Infusions of ABBV-313 Affects the Body of Adult Participants
AbbVie
- Location
- Grayslake, IL + 1 other US site
- Eligibility basics
- Ages 18–55
- RecruitingHealthy volunteersPhase 1
A Study to Evaluate the Safety and Pharmacokinetics of Multiple Doses Upadacitinib, Tofacitinib, and Baricitinib in Healthy Adult Volunteers
AbbVie
- Location
- Grayslake, IL
- Eligibility basics
- Ages 18–65